Document is current

Any future updates will be listed below

Publisher Correction: Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer

Crossref DOI link: https://doi.org/10.1038/s41598-024-67606-5

Published Online: 2024-07-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark